HercepTest™ mAb pharmDx is the latest addition to the strong Dako Omnis product portfolio, which includes a wide range of ready-to-use antibodies including ER, PR, Ki-67 and MMR, multiple ISH probes, the HER2 IQFISH assay and our market leading PD-L1 IHC 22C3 pharmDx assay.
HercepTest™ mAb pharmDx for Dako Omnis supports easy interpretation and reliable staining results of breast cancer specimens, thanks to its newly developed rabbit monoclonal antibody and the Dako Omnis staining quality. HercepTest™ mAb pharmDx has proven concordance with HercepTest™ for Automated Link Platforms and HER2 IQFISH.
Designed for managing whole patient cases, Dako Omnis enables continuous delivery of complete patient cases to pathologists throughout the day. Patient case management supports your lab in completing more patient cases the same day they are requested and enabling fast diagnosis to patients when they need it the most.
The licensed antibody is created by Epitomics Inc. (an Abcam company), using Abcam’s proprietary rabbit monoclonal antibody technology covered under Patent No’s 5,675,063 and 7,402,409.
D61582
Please note that HercepTest™ mAb pharmDx (Dako Omnis) is launched in Europe only and is not available in all countries. Contact us to hear about availability in your country.
Newsletters
Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.
